Insider · CIK 0001891900

Teehan Brendan

Reports to the SEC for 2 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001891900

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-11	PCRXPacira BioSciences, Inc.A Award	Chief Commercial Officer	AAward	+51.7K sh	—	—	100,934.268
2026-01-30	PCRXPacira BioSciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−5,182 sh	$20.54	−$106K	49,220.268
2025-12-31	PCRXPacira BioSciences, Inc.A Award	Chief Commercial Officer	AAward	+402.268 sh	$10.76	+$4,329.61	54,402.268
2025-02-04	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+99.5K sh	$26.59	+$2.65M	99,500
2025-02-01	PCRXPacira BioSciences, Inc.A Award	Chief Commercial Officer	AAward	+54K sh	—	—	54,000
2024-11-19	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−10.3K sh	$16.81	−$174K	62,105
2024-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+9,913 sh	—	—	62,521
2024-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+9,913 sh	—	—	72,434
2024-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−9,913 sh	—	—	9,913
2024-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−9,913 sh	—	—	9,913
2024-08-19	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−9,534 sh	$15.28	−$146K	52,177
2024-08-16	ACADACADIA PHARMACEUTICALS INCA Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+5,024 sh	—	—	48,082
2024-08-16	ACADACADIA PHARMACEUTICALS INCA Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+13.6K sh	—	—	61,711
2024-05-02	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−3,477 sh	$16.94	−$58.9K	42,133
2024-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+6,814 sh	—	—	45,610
2024-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−6,814 sh	—	—	20,445
2024-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−2,568 sh	$17.87	−$45.9K	38,796
2024-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+5,024 sh	—	—	41,364
2024-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−5,024 sh	—	—	10,048
2024-03-27	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−5,140 sh	$17.90	−$92K	36,340
2024-03-25	ACADACADIA PHARMACEUTICALS INCA Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+10K sh	—	—	41,480
2024-03-25	ACADACADIA PHARMACEUTICALS INC · Stock Options (Right to Buy)A Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+89.5K sh	—	—	89,516
2024-03-25	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+27.5K sh	—	—	27,460
2024-02-26	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−624 sh	$24.67	−$15.4K	31,432
2024-02-23	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+1,107 sh	—	—	32,056
2024-02-23	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−1,107 sh	—	—	1,107
2024-01-08	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−731 sh	$29.96	−$21.9K	30,949
2024-01-06	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+1,287 sh	—	—	31,680
2024-01-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−1,287 sh	—	—	0
2023-11-20	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−4,960 sh	$22.64	−$112K	30,393
2023-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+4,956 sh	—	—	30,397
2023-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+4,956 sh	—	—	35,353
2023-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−4,956 sh	—	—	19,826
2023-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−4,956 sh	—	—	19,826
2023-05-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+14.9K sh	—	—	24,356
2023-05-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+14.9K sh	—	—	39,225
2023-05-17	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−14.9K sh	$22.50	−$335K	24,356
2023-05-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−14.9K sh	—	—	24,782
2023-05-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−14.9K sh	—	—	24,782
2023-05-01	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−548 sh	$21.18	−$11.6K	9,487
2023-05-01	ACADACADIA PHARMACEUTICALS INC · Stock Options (Right to Buy)A Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+89.9K sh	—	—	89,936
2023-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, COO, HEAD OF COMMERCIAL	AAward	+27.3K sh	—	—	27,259
2023-04-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+1,567 sh	—	—	10,035
2023-04-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−1,567 sh	—	—	0
2023-04-06	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−1,751 sh	$18.16	−$31.8K	8,468
2023-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+5,024 sh	—	—	10,219
2023-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−5,024 sh	—	—	15,072
2023-02-24	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, COO, HEAD OF COMMERCIAL	SSale	−461 sh	$18.78	−$8,657.58	5,195
2023-02-23	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	+1,107 sh	—	—	5,656
2023-02-23	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, COO, HEAD OF COMMERCIAL	MExercise/Conversion	−1,107 sh	—	—	2,214

Recent filings

Accepted (ET)
Feb 134
Teehan Brendan0001628280-26-008077
SEC(opens sec.gov)
Feb 34
Teehan Brendan0001628280-26-005154
SEC(opens sec.gov)
Jan 64
Teehan Brendan0001628280-26-000964
SEC(opens sec.gov)
Feb 44
Teehan Brendan0001396814-25-000030
SEC(opens sec.gov)
Nov 194
Teehan Brendan0001415889-24-027294
SEC(opens sec.gov)
Aug 204
Teehan Brendan0001415889-24-021726
SEC(opens sec.gov)
May 34
Teehan Brendan0001415889-24-012239
SEC(opens sec.gov)
Apr 94
Teehan Brendan0001415889-24-010603
SEC(opens sec.gov)
Mar 274
Teehan Brendan0001415889-24-009272
SEC(opens sec.gov)

Companies

Address

C/O PACIRA BIOSCIENCES, INC. 2000 SIERRA POINT PARKWAY, SUITE 900

BRISBANE, CA, 94005